$2.19
+0.08 (+3.79%)
Open$2.14
Previous Close$2.11
Day High$2.20
Day Low$2.10
52W High$3.90
52W Low$2.02
Volume—
Avg Volume244.7K
Market Cap223.90M
P/E Ratio—
EPS$-0.43
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+985.8% upside
Current
$2.19
$2.19
Target
$23.78
$23.78
$21.93
$23.78 avg
$37.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.63M | 3.74M | 119.79M |
| Net Income | -71,485,007 | -66,244,343 | 199.8K |
| Profit Margin | -1,971.7% | -1,873.1% | 0.2% |
| EBITDA | -67,804,429 | -66,324,348 | 316.5K |
| Free Cash Flow | — | — | 248.3K |
| Rev Growth | -2.9% | -2.9% | -0.9% |
| Debt/Equity | 0.10 | 0.10 | 0.69 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |